StonvexLoading…
StonvexStonvexStonvexCore line items from AXIL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $22.29M | $14.99M | $6.86M | $26.26M |
Operating Income | $1.53M | $1.31M | $411.74K | $1.16M |
Net Income | $1.24M | $1.04M | $334.29K | $854.99K |
EPS (Diluted) | $0.15 | $0.13 | $0.04 | $0.10 |
Total Assets | $15.18M | $16.24M | $15.36M | $12.87M |
Total Liabilities | $3.72M | $5.16M | $5.16M | $3.21M |
Cash & Equivalents | $5.52M | $4.98M | $4.09M | $4.77M |
Free Cash Flow OCF − CapEx | $711.62K | $158.80K | $-747.56K | $1.72M |
Shares Outstanding | 6.82M | 6.80M | 6.66M | 6.66M |